Doctor View: Medical not expected to be an issue as Leeds ready to sign Brazilian midfielder…

Doctor View: Medical issues are not anticipated as Leeds prepares to sign Brazilian midfielder.

Leeds United is reportedly interested in acquiring Sheffield United midfielder Gustavo Hamer this summer.

Dr. Rajpal Brar, an expert in injuries, has evaluated his fitness history in anticipation of a possible medical examination in the upcoming weeks.

The 28-year-old is set to compete in the second tier next season unless he departs from the Blades, as they were unable to achieve promotion to the Premier League.

Hamer is expected to have no problems passing his medical examination.

Dr. Brar indicates that the Brazilian’s fitness history implies he should clear his medical without any issues.

Leeds is prepared to sign Hamer, as he is eager to leave following his team’s failure to secure promotion. [talkSPORT, 27 May]

In an exclusive interview with MOT Leeds News, Dr. Brar, a Physical Therapy specialist and Sports Scientist, commented on Hamer: “He had a campaign free of injuries, which is promising for any club interested in signing him.

“I do not foresee any complications with his medical examination, either.

“In recent seasons, there have been no concerning aspects regarding his fitness record, and he is at an advantageous age as well.”

Leeds United should reconsider signing Hamer.

Hamer would have been a valuable asset for Leeds United in the Championship, where his technical skills, work ethic, and creativity were evident at Coventry City.

His vision and proficiency in set-pieces would have aligned well with the requirements of the second tier.

However, in the Premier League, Hamer’s shortcomings render him a precarious target.

His defensive discipline is often erratic, creating gaps in midfield, and his passing can lack the accuracy necessary against top-tier teams.

The Elland Road club, aiming to strengthen their Premier League position after promotion, requires players with established elite-level capabilities.

Pursuing Hamer would be a risk, diverting resources from acquisitions that are better suited to cope with the division’s relentless demands.